erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
a sign at a planned parenthood clinic is pictured in oklahoma city, in 2015..
chat with us in facebook messenger. find out what's happening in the world as it unfolds..
.
email